Skip to menu Skip to content Skip to footer

1998

Journal Article

Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation

Hill, GR, Cooke, KR, Teshima, T, Crawford, JM, Keith, JC, Brinson, YS, Bungard, D and Ferrara, JLM (1998). Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. Journal of Clinical Investigation, 102 (1), 115-123. doi: 10.1172/JCI3132

Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation

1997

Journal Article

The role of cytokines in acute graft-versus-host disease

Hill, GR, Krenger, W and Ferrara, JLM (1997). The role of cytokines in acute graft-versus-host disease. Cytokines Cellular & Molecular Therapy, 3 (4), 257-265.

The role of cytokines in acute graft-versus-host disease

1997

Journal Article

Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines

Hill, GR, Crawford, JM, Cooke, KR, Brinson, YS, Pan, LY and Ferrara, JLM (1997). Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines. Blood, 90 (8), 3204-3213.

Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines

1997

Journal Article

Cytokine cascades in acute graft-versus-host disease

Krenger, W, Hill, GR and Ferrara, JLM (1997). Cytokine cascades in acute graft-versus-host disease. Transplantation, 64 (4), 553-558. doi: 10.1097/00007890-199708270-00001

Cytokine cascades in acute graft-versus-host disease

1997

Journal Article

The use of low dose Orgaran in heparin-induced thrombocytopenia associated with in vitro platelet aggregation at higher Orgaran concentrations

Hill, GR, Hickton, C, Henderson, S and Patton, WN (1997). The use of low dose Orgaran in heparin-induced thrombocytopenia associated with in vitro platelet aggregation at higher Orgaran concentrations. Clinical and Laboratory Haematology, 19 (2), 155-157. doi: 10.1046/j.1365-2257.1997.00052.x

The use of low dose Orgaran in heparin-induced thrombocytopenia associated with in vitro platelet aggregation at higher Orgaran concentrations

1996

Journal Article

Pulmonary hypertension as a consequence of alveolar capillary plugging by malignant megakaryocytes in essential thrombocythaemia

Hill, G, McClean, D, Fraser, R, Hart, D, Crozier, , Snowden, J and Gibbons, S (1996). Pulmonary hypertension as a consequence of alveolar capillary plugging by malignant megakaryocytes in essential thrombocythaemia. Australian and New Zealand Journal of Medicine, 26 (6), 852-853. doi: 10.1111/j.1445-5994.1996.tb00642.x

Pulmonary hypertension as a consequence of alveolar capillary plugging by malignant megakaryocytes in essential thrombocythaemia

1996

Journal Article

Acquired heparin-like anticoagulants: A second case in metastatic breast carcinoma and literature review

Hill, GR, Hickton, CM, Brennan, SO, Atkinson, CH and Heaton, DC (1996). Acquired heparin-like anticoagulants: A second case in metastatic breast carcinoma and literature review. Clinical and Laboratory Haematology, 18 (4), 291-295.

Acquired heparin-like anticoagulants: A second case in metastatic breast carcinoma and literature review

1996

Journal Article

High dose therapy and autologous bone marrow versus blood cell rescue

Hill, GR, Inder, A and Patton, WN (1996). High dose therapy and autologous bone marrow versus blood cell rescue. New Zealand Medical Journal, 109 (1016), 45-48.

High dose therapy and autologous bone marrow versus blood cell rescue

1996

Journal Article

Donor leukocyte infusions in the treatment of chronic myeloid leukemia in relapse post bone marrow transplantation

Hill, GR, Hart, DNJ, Moore, AF and Morris, CM (1996). Donor leukocyte infusions in the treatment of chronic myeloid leukemia in relapse post bone marrow transplantation. Pathology, 28 (1), 51-53. doi: 10.1080/00313029600169523

Donor leukocyte infusions in the treatment of chronic myeloid leukemia in relapse post bone marrow transplantation